Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation

Neuroscience Research

Volumn 62, Issue 2, 2008, Pages 105-111

  Matsuura, Nobuyuki ^a   Shibukawa, Yoshiyuki ^a   Kato, Motoichiro ^a,b   Ichinohe, Tatsuya ^a   Suzuki, Takashi ^a   Kaneko, Yuzuru ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CO2 laser; Fentanyl; Ketamine; Magnetoencephalography; Secondary somatosensory area; Somatosensory evoked magnetic field

Indexed keywords

ANALGESIC AGENT; FENTANYL; FENTANYL CITRATE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; OPIATE RECEPTOR;

ADULT; AMPLITUDE MODULATION; ARTICLE; CARBON DIOXIDE LASER; CONTINUOUS INFUSION; EVOKED SOMATOSENSORY RESPONSE; HUMAN; HUMAN EXPERIMENT; MAGNETIC FIELD; MAGNETOENCEPHALOGRAPHY; MALE; NORMAL HUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; TRIGEMINAL NERVE;

ADULT; ANALGESICS; FACIAL PAIN; FENTANYL; HUMANS; KETAMINE; LASERS, GAS; MAGNETOENCEPHALOGRAPHY; MALE; NOCICEPTORS; RECEPTORS, N-METHYL-D-ASPARTATE; SKIN; SOMATOSENSORY CORTEX; TRIGEMINAL NERVE;

EID: 50449099125     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.06.006     Document Type: Article

References (37)

1. Anis N.A., Berry S.C., Burton N.R., and Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methylaspartate. Br. J. Pharmacol. 79 (1983) 565-575
2. Apkarian A.V., Bushnell M.C., Treede R.D., and Zubieta J.K. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain. 9 (2005) 463-484
3. Bessho H., Shibukawa Y., Shintani M., Yajima Y., Suzuki T., and Shibahara T. Topographic Localization of the Palate Area in Human Somatosensory Cortex. J. Dent. Res. 86 (2007) 265-270
4. Bromm B. Neurophysiological correlates of pain. In: Bromm B. (Ed). Pain Measurement in Man (1984), Elsevier, Amsterdam 3-13
5. Bromm B., and Treede R.D. Laser evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and in patients. Rev. Neurol. (Paris) 147 (1991) 625-643
6. Casey K.L., Minoshima S., Morrow T.J., and Koeppe R.A. Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J. Neurophysiol. 76 (1996) 571-581
7. Coghill R.C., Sang C.N., Maisog J.M., and Iadarola M.J. Pain intensity processing within the human brain: a bilateral, distributed mechanism. J. Neurophysiol. 82 (1999) 1934-1943
8. Eide P.K., Jorum E., Stubhaug A., Bremnes J., and Breivik H. Relief of post- herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58 (1994) 347-354
9. Hämäläinen M., Hari R., Ilmoniemi R., Knuutila J., and Lounasmaa O. Magnetoencephalography - theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev. Mod. Phys. 65 (1993) 413-497
10. Huskisson E.C. Measurement of pain. Lancet 2 (1974) 1127-1131
11. Inui K., Tran T.D., Qiu Y., Wang X., Hoshiyama M., and Kakigi R. A comparative magnetoencephalographic study of cortical activations evoked by noxious and innocuous somatosensory stimulations. Neuroscience 120 (2003) 235-248
12. Inui K., Wang X., Qiu Y., Nguyen B.T., Ojima S., Tamura Y., Nakata H., Wasaka T., Tran T.D., and Kakigi R. Pain processing within the primary somatosensory cortex in humans. Eur. J. Neurosci. 18 (2003) 2859-2866
13. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., and Nakanish S. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J. Biol. Chem. 268 (1993) 2836-2843
14. 2 laser stimulation in man. Neurosci. Lett. 192 (1995) 45-48
15. Kakigi R., Tran T.D., Qiu Y., Wang X., Nguyen T.B., Inui K., Watanabe S., and Hoshiyama M. Cerebral responses following stimulation of unmyelinated C-fibers in humans: electro- and magneto-encephalographic study. Neurosci. Res. 45 (2003) 255-275
16. Kanda M., Nagamine T., Ikeda A., Ohara S., Kunieda T., Fujiwara N., Yazawa S., Sawamoto N., Matsumoto R., Taki W., and Shibasaki H. Primary somatosensory cortex is actively involved in pain processing in human. Brain Res. 853 (2000) 282-289
17. Kato Y., Muramatsu T., Kato M., Shibukawa Y., Shintani M., and Yoshino F. Cortical reorganization and somatic delusional psychosis: an MEG study. Psychiatry Res. 146 (2006) 91-95
18. Kenton B., Coger R., Crue B., Pinsky J., Friedman Y., and Carmon A. Peripheral fiber correlates to noxious thermal stimulation in humans. Neurosci. Lett. 17 (1980) 301-306
19. Kohrs R., and Durieux M.E. Ketamine: teaching and old drug new tricks. Anesth. Analg. 87 (1998) 1186-1193
20. Kubo K., Shibukawa Y., Shintani M., Suzuki T., Ichinohe T., and Kaneko Y. Cortical representation area of human dental pulp. J. Dent. Res. 87 (2008) 358-362
21. Mathisen L.C., Skjelbred P., Skoglund L.A., and Øye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61 (1995) 215-220
22. Maurset A., Skoglund L.A., Hustveit O., and Øye I. Comparison of ketamine and pethidine in experimental and postoperative pain. Pain 36 (1989) 37-41
23. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221
24. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., and Jensen T.S. The effect of ketamine on phantom pain. A central neuropathic disorder maintained by peripheral input. Pain 67 (1996) 69-77
25. Oga K., Kojima T., Matsuura T., Nagashima M., Kato J., Saeki S., and Ogawa S. Effects of low-dose ketamine on neuropathic pain: an electroencephalogram-electrooculogram/behavioral study. Psychiatry Clin. Neurosci. 56 (2002) 355-363
26. Ploner M., Schmitz F., Freund H.J., and Schnitzler A. Parallel activation of primary and secondary somatosensory cortices in human pain processing. J. Neurophysiol. 81 (1999) 3100-3104
27. Rabben T. Effect of the NMDA receptor antagonist ketamine in electrically induced Aδ-fiber pain. Methods Find Exp. Clin. Pharmacol. 22 (2000) 185-189
28. Rabben T., and Øye I. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain. Eur. J. Pain 5 (2001) 233-240
29. Roytblat L., Korotkoruchko A., Katz J., Glazer M., Greemberg L., and Fisher A. Postoperative pain: the effect of low-dose ketamine in addition to general anesthesia. Anesth. Analg. 77 (1993) 1161-1165
30. Shibukawa Y., Shintani M., Kumai T., Suzuki T., and Nakamura Y. Cortical magnetic fields in association with voluntary jaw movements. J. Dent. Res. 83 (2004) 572-577
31. Shibukawa Y., Ishikawa T., Kato Y., Zhang Z.K., Jiang T., Shintani M., Shimono M., Kumai T., Suzuki T., Kato M., and Nakamura Y. Cerebral cortical dysfunction in patients with temporomandibular disorders in association with jaw movement observation. Pain 128 (2007) 180-188
32. Stannard C., and Porter G.E. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 54 (1993) 227-230
33. Taddese A., Nah S.Y., and McCleskey E.W. Selective opioid inhibition of small nociceptive neurons. Science 270 (1995) 1366-1369
34. Uusitalo M.A., and Ilmoniemi R.J. Signal-space projection method for separating MEG or EEG into components. Med. Biol. Eng. Comput. 35 (1997) 135-140
35. Wang X., Inui K., and Kakigi R. Early cortical activities evoked by noxious stimulation in humans. Exp. Brain Res. 180 (2007) 481-489
36. Watanabe S., Kakigi R., Koyama S., Hoshiyama M., and Kaneoke Y. Pain processing by magnetoencephalography in the human brain. Brain Topogr. 10 (1998) 255-264
37. Yamasaki H., Kakigi R., Watanabe S., and Nak D. Effect of distraction on pain perception: magneto- and electro-encephalographic studies. Brain Res. Cogn. Brain Res. 8 (1999) 73-76